Ignite Creation Date:
2025-12-25 @ 12:05 AM
Ignite Modification Date:
2025-12-25 @ 10:03 PM
Study NCT ID:
NCT06981858
Status:
NOT_YET_RECRUITING
Last Update Posted:
2025-05-21
First Post:
2025-05-13
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
A Single-Arm Exploratory Study of Enlansibumab Sequentially Combined With Concurrent Chemoradiotherapy for Locally Advanced Cervical Cancer
Sponsor:
Chongqing University Cancer Hospital
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2025-05-15
Start Date Type:
ESTIMATED
Primary Completion Date:
2029-02-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2029-02-01
Completion Date Type:
ESTIMATED
First Submit Date:
2025-05-13
First Submit QC Date:
None
Study First Post Date:
2025-05-21
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-05-13
Last Update Post Date:
2025-05-21
Last Update Post Date Type:
ACTUAL